TECTONIC THERAPEUTIC INC (TECX) Stock Price, Quote, News and Overview
NASDAQ:TECX - Nasdaq - US8789721086 - Common Stock - Currency: USD
TECX Quote, Performance and Key Statistics
25.28
-0.29 (-1.13%)
The current stock price of TECX is 25.28 USD. In the past month the price decreased by -53.9%.
TECX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.66 | 369.39B | ||
| AMGN | AMGEN INC | 15.54 | 165.43B | ||
| GILD | GILEAD SCIENCES INC | 24.8 | 142.43B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1654.45 | 123.26B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.31 | 76.39B | ||
| ARGX | ARGENX SE - ADR | 242.12 | 37.96B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.83B | ||
| ONC | BEIGENE LTD-ADR | N/A | 29.00B | ||
| BNTX | BIONTECH SE-ADR | N/A | 27.07B | ||
| NTRA | NATERA INC | N/A | 20.54B | ||
| BIIB | BIOGEN INC | 8.53 | 20.47B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 15.26B |
Related stock screener links
About TECX
Company Profile
Tectonic Therapeutic Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Watertown, Massachusetts and currently employs 13 full-time employees. The company went IPO on 2018-06-21. Tectonic Therapeutic, Inc. is a biotechnology company. The firm is focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). Leveraging its technology platform called GEODe (GPCRs Engineered for Optimal Discovery), the Company is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. The Company’s lead program, TX000045 (TX45), is an Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone relaxin. TX45 is being evaluated in Phase Ia/Ib clinical trials as a potential treatment for Group 2 Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (HFpEF). Its second program addresses Hereditary Hemorrhagic Telangiectasia (HHT).
Company Info
TECTONIC THERAPEUTIC INC
490 Arsenal Way, Suite 210
Watertown MASSACHUSETTS US
Employees: 13
Company Website: https://tectonictx.com/
Investor Relations: https://investors.avrobio.com/
Phone: 13396663320
TECTONIC THERAPEUTIC INC / TECX FAQ
What is the stock price of TECTONIC THERAPEUTIC INC today?
The current stock price of TECX is 25.28 USD. The price decreased by -1.13% in the last trading session.
What is the ticker symbol for TECTONIC THERAPEUTIC INC stock?
The exchange symbol of TECTONIC THERAPEUTIC INC is TECX and it is listed on the Nasdaq exchange.
On which exchange is TECX stock listed?
TECX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for TECTONIC THERAPEUTIC INC stock?
10 analysts have analysed TECX and the average price target is 87.38 USD. This implies a price increase of 245.65% is expected in the next year compared to the current price of 25.28. Check the TECTONIC THERAPEUTIC INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is TECTONIC THERAPEUTIC INC worth?
TECTONIC THERAPEUTIC INC (TECX) has a market capitalization of 372.88M USD. This makes TECX a Small Cap stock.
How many employees does TECTONIC THERAPEUTIC INC have?
TECTONIC THERAPEUTIC INC (TECX) currently has 13 employees.
Should I buy TECTONIC THERAPEUTIC INC (TECX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TECX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TECX, evaluating the profitability, health, valuation and growth aspects
- TECTONIC THERAPEUTIC INC (TECX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- TECTONIC THERAPEUTIC INC (TECX) Sales and EPS estimates to see what analysts future expectations are.
- TECTONIC THERAPEUTIC INC (TECX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- TECTONIC THERAPEUTIC INC (TECX) Insider and Institutional Ownership to learn about the owners and their transactions.
- TECTONIC THERAPEUTIC INC (TECX) Stock Chart to make your own analysis
- TECTONIC THERAPEUTIC INC (TECX) Latest news and press-releases to stay up to date.
Does TECTONIC THERAPEUTIC INC (TECX) stock pay dividends?
TECX does not pay a dividend.
When does TECTONIC THERAPEUTIC INC (TECX) report earnings?
TECTONIC THERAPEUTIC INC (TECX) will report earnings on 2025-03-12, after the market close.
What is the Price/Earnings (PE) ratio of TECTONIC THERAPEUTIC INC (TECX)?
TECTONIC THERAPEUTIC INC (TECX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-9.74).
What is the Short Interest ratio of TECTONIC THERAPEUTIC INC (TECX) stock?
The outstanding short interest for TECTONIC THERAPEUTIC INC (TECX) is 13.77% of its float. Check the ownership tab for more information on the TECX short interest.
TECX Technical Analysis
TECX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TECX. TECX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
TECX Financial Highlights
Over the last trailing twelve months TECX reported a non-GAAP Earnings per Share(EPS) of -9.74. The EPS decreased by -399.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -32.24% | ||
| ROE | -36.18% | ||
| Debt/Equity | 0 |
TECX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to TECX. The Buy consensus is the average rating of analysts ratings from 10 analysts.